fluvoxamine - CISMeF

Preferred Label : fluvoxamine;

MeSH definition : A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS.;

CISMeF synonym : pharmacia brand of fluvoxamine maleate; arrow brand of fluvoxamine maleate; eurim brand of fluvoxamine maleate; 54739-20-7 (Fluvoxamine maleate, (E)-Isomer); 61718-82-9 (Fluvoxamine maleate); novopharm brand of fluvoxamine maleate; Nu-Pharm brand of fluvoxamine maleate; nu pharm brand of fluvoxamine maleate; pharmascience brand of fluvoxamine maleate; declimed brand of fluvoxamine maleate; merck dura brand of fluvoxamine maleate; aliud brand of fluvoxamine maleate; betapharm brand of fluvoxamine maleate; stadapharm brand of fluvoxamine maleate; neuraxpharm brand of fluvoxamine maleate; ratiopharm brand of fluvoxamine maleate; geminis brand of fluvoxamine maleate; solvay brand of fluvoxamine maleate;

MeSH hyponym : desiflu; PMS-Fluvoxamine; fluvoxamin-neuraxpharm; fluvoxamin AL; fluvoxamina geminis; fluvoxamin-ratiopharm; Novo-Fluvoxamine; Nu-Fluvoxamine; fluvoxamin stada; fluvoxamin beta; luvox; fluvoxadura; fluvoxamine maleate; DU-23000; Fluvoxamin neuraxpharm; Fluvoxamin ratiopharm; ratio-Fluvoxamine; ratio Fluvoxamine; Geminis, Fluvoxamina; Fluvoxamine Maleate, (E)-Isomer; Floxyfral; Fevarin; Dumirox; Faverin; Novo Fluvoxamine; Nu Fluvoxamine; PMS Fluvoxamine; DU 23000; DU23000;

Related MeSH term : fluvoxamine, (Z)-Isomer;

MeSH CAS label : 1-Pentanone, 5-methoxy-1-(4-(trifluoromethyl)phenyl)-, O-(2-aminoethyl)oxime, (E)-;

MeSH Related Number : fluvoxamine maleate; fluvoxamine, (Z)-Isomer; 54739-18-3 (Fluvoxamine); 61718-82-9 (maleate); 89035-92-7 ((Z)-isomer); 5LGN83G74V;

Registry Number MeSH : 54739-18-3;

Related CAS MeSH : 89035-92-7 (Fluvoxamine, (Z)-Isomer); 5LGN83G74V (Fluvoxamine maleate);

Wikipedia link : https://en.wikipedia.org/wiki/Fluvoxamine;

Is substance : O;

UNII : O4L1XPO44W;

InChIKey : CJOFXWAVKWHTFT-XSFVSMFZSA-N;

Details

Origin ID

D016666;

UMLS CUI

C0085228;

ATC code(s)
- fluvoxamine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Fluvoxamine maleate [Substance BNPC]
CISMeF manual mappings
- Fluvoxamine poisoning (disorder) [SNOMED CT concept]
- fluvoxamine [Substance BNPC]
Currated CISMeF NLP mapping
- Fluvoxamine [ICD-11 Extension code]
- Fluvoxamine [ICHI extension code]
- Fluvoxamine [SMS substance]
- Fluvoxamine [NCIt concept]
- Fluvoxamine (substance) [SNOMED CT concept]
- fluvoxaMINE [LOINC component]
- fluvoxamine [SNOMED Notion]
Pharmacological action(s)
- Cytochrome P-450 CYP1A2 Inhibitors [MeSH Descriptor]
- Cytochrome P-450 CYP2C19 Inhibitors [MeSH Descriptor]
- Selective Serotonin Reuptake Inhibitors [MeSH Descriptor]
- anti-anxiety agents [MeSH Descriptor]
- antidepressive agents, second-generation [MeSH Descriptor]
- central nervous system depressants [MeSH Descriptor]
Record concept(s)
- DU-23000 [MeSH concept]
- Novo-Fluvoxamine [MeSH concept]
- Nu-Fluvoxamine [MeSH concept]
- PMS-Fluvoxamine [MeSH concept]
- desiflu [MeSH concept]
- fluvoxadura [MeSH concept]
- fluvoxamin AL [MeSH concept]
- fluvoxamin beta [MeSH concept]
- fluvoxamin stada [MeSH concept]
- fluvoxamin-neuraxpharm [MeSH concept]
- fluvoxamin-ratiopharm [MeSH concept]
- fluvoxamina geminis [MeSH concept]
- fluvoxamine [MeSH concept]
- fluvoxamine maleate [MeSH concept]
- fluvoxamine, (Z)-Isomer [MeSH concept]
- luvox [MeSH concept]
Related MeSH Supplementary Concept(s)
- O-methyl-fluvoxamine [MeSH Supplementary Concept]
- fluvoxamino acid [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Drug-induced photosensitivity (disorder) [SNOMED CT concept]
- Fluvoxamine Measurement [NCIt concept]
- Product containing fluvoxamine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Fluvoxamine [ICD-11 Extension code]
- Fluvoxamine [NCIt concept]
- Fluvoxamine (substance) [SNOMED CT concept]
- Product containing fluvoxamine (medicinal product) [SNOMED CT concept]
- fluvoxaMINE [LOINC component]
- fluvoxamine [ATC Code]
- fluvoxamine [Substance BNPC]
- fluvoxamine [SNOMED Notion]
Validated automatic mappings to BTNT
- Fluvoxamine Maleate [NCIt concept]
- Fluvoxamine maleate [Substance BNPC]
- Fluvoxamine maleate [SMS substance]
- Fluvoxamine maleate (substance) [SNOMED CT concept]
- fluvoxamine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients